Supply chain & logistics Supply chain & logistics
Good things,
small packages
Containers have been an inescapable part of the pharma supply chain forever – but it’s only with the rise of sophisticated new treatments, and the consequences of the pandemic, that insiders have begun sweeping away antiquated technologies. Andrea Valentino talks to Patricia Turney, senior vice president of operations at Arcutis Biotherapeutics, to understand why the pharma supply chain has grown in importance over recent years, the limitations of traditional drug containers – and what the so-called hybrid model could mean for both drug delivery and the planet.
he raw numbers, we can all agree, are astonishing. Since Covid-19 vaccines first appeared in December 2020, 11 billion doses have been administered worldwide, spread across 184 countries. According to the latest figures by Bloomberg, that means around 28.1 million shots are entering arms every single day, altogether representing 132 shots for every 100 people. The
T 34
same goes for individual countries. In the US, by no means the world’s outstanding vaccination hub, 547 million doses have so far been doled out from sea to shining sea, and even that pales compared to success stories like Portugal or Cuba. Yet if the vaccine rollout is one of the great scientific feats of modern times – we should never forget it is also a feat of logistics.
World Pharmaceutical Frontiers /
www.worldpharmaceuticals.net
Ilin Sergey/
www.shutterstock.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53
